Evidence map›Paper›PMID 38791902›Full record

ArticleCancers2024

Frequency of Common and Uncommon

Amit Mahipal, Michael H Storandt, Emily A Teslow, Ellen Jaeger, Melissa C Stoppler, Zhaohui Jin, Sakti Chakrabarti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amit MahipalDepartment of Medical Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-1111-8333
Michael H StorandtDepartment of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-1266-7393
Emily A TeslowTempus AI, Chicago, IL 60654, USA.ORCID 0000-0001-5506-1749
Ellen JaegerTempus AI, Chicago, IL 60654, USA.ORCID 0009-0005-1386-614X
Melissa C StopplerTempus AI, Chicago, IL 60654, USA.
Zhaohui JinDepartment of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-7844-5833
Sakti ChakrabartiDepartment of Medical Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-1582-098X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe predictive and prognostic role of

methodsPatients with CRC and non-CRC GI malignancies who underwent somatic tumor profiling via a tissue-based or liquid-based assay were included in this study. Gain-of-function

resultsAmong 51,560 patients with somatic profiling, 40% had CRC and 60% had non-CRC GI malignancies.

conclusionsNon-CRC GI malignancies demonstrate a distinct

Indexed as

BRAFcolorectal cancergastrointestinal cancer

Identifiers

PMID38791902
PMCPMC11119877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.